Dawnrays Pharmaceutical Holdings Ltd. (HK:2348) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Dawnrays Pharmaceutical (Holdings) Ltd. has announced the resignation of its CEO, Mr. Wu Weixian, effective from 5:00 pm on 11 September 2024, due to his desire to focus on personal commitments. The company is actively seeking a replacement and will update shareholders and the Hong Kong Stock Exchange once a suitable candidate is found. The board extends its gratitude to Mr. Wu for his services during his tenure.
For further insights into HK:2348 stock, check out TipRanks’ Stock Analysis page.